Nemis
NEMIS Technologies is a biotechnology company which develops diagnostic kits and solutions for accelerated microbiological.
Nemis has raised €11M across 2 funding rounds, most recently a Series A round in Feb 2022. Based in Zurich, Switzerland; founded 2018; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€11M
€10,539,281
Funding rounds
2
Investors
0
distinct backers
Active since
2020-03
latest 2022-02
Funding by year
EUR raised per yearNemis — funding by year — interactive chart.
Data table
| Nemis — funding by year | |
|---|---|
| 2020 | €3.2M |
| 2022 | €7.3M |
Signals
Medium confidenceRaise-next likelihood10
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood8
base rate 11% (2+ rounds)
- ▲ 8y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-02-05 | Series A | €7.3M | — | View deal → |
| 2020-03-16 | Series B | €3.2M | — | View deal → |
Related news
- Nemis Technologies closes CHF7.75 million Series A funding roundstartupticker.ch · 2022-02
- startupticker.ch
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData